Product Highlight - LYPSTAPLUS

• Rosuvastatin and Ezetimibe, now in a Single pill¹
• In patients with Hypercholesterolemia, Effective and Safe LDL-C lowering therapy¹, with convenience in a Single pill
• Recommended dosage:1 film-coated tablet daily with or without food
• Fixed-dose combinations like Lypstaplus, can bring multiple benefits to patients – Improved Adherence², Convenience³ and Reduced Hospitalization⁴

References:
1. Ference BA, et al. Eur Heart J 2017;38:2459-72.
2. Castellano JM, et al. J Am Coll Cardiol. 2014;64:2017-2081.
3. Lypstaplus Singapore prescribing information, 2023.
4. Aubert RE, et al. Am J Manag Care 2010;16:459–466SIN2308511.

Abbott Laboratories (S) Pte Ltd
3 Fraser Street #23-28 DUO Tower, Singapore 189352
Tel: (+65) 6914 8000 ∙ Fax: (+65) 6914 8002 ∙ Website: www.abbott.com.sg

Related MIMS Drugs

LYPSTAPLUS